PRMT9 inhibition sparks immune responses in AML

Nat Cancer. 2024 Apr;5(4):539-541. doi: 10.1038/s43018-024-00753-w.

Antonella Santoro¹, Raffaella Di Micco^{2

3}

¹ San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Unit of Senescence in Stem Cell Aging, Differentiation and Cancer, Milano, Italy.
² San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Unit of Senescence in Stem Cell Aging, Differentiation and Cancer, Milano, Italy. dimicco.raffaella@hsr.it.
³ University School for Advanced Studies IUSS, Pavia, Italy. dimicco.raffaella@hsr.it.

No abstract available

MeSH terms